Pelago receives funding

Tuesday November 20, 2018

Pelago receives funding from Vinnova to develop miniaturization of CETSA®

The nano scaling of CETSA® is part of a project that receives funding in the innovation challenge from Vinnova. The project title is ”Sverige som testbädd för framtidens läkemedelsutveckling i nanoskala” where minaturization of CETSA® is key for a successful outcome.

The project is a collaboration between Pelago Bioscience, Karolinska Institute, the Royal Institute of Technology, Science for Life Laboratory, AstraZeneca, Takara Bio, and Labcyte. One of eight projects receiving funding on a total of 107 Msek in this call for funding from Vinnova.

Click here for more information (in Swedish).

Review Article on CETSA®